About Us

About Matrivax

Matrivax is a clinical-stage biotechnology company developing human vaccines for the prevention and treatment of life-threatening infectious diseases.

Our mission is to develop novel approaches to vaccine design and to create clinically-important vaccines which address public health on a global scale. 

Our pipeline includes two vaccine candidates implementing proprietary protective antigens against Streptococcus pneumoniae (MVX01) and Clostridioides difficile (MVX02).

Matrivax is a privately-held company proudly based in the biotechnology hub of Boston, Massachusetts.

© 2020 Matrivax Research and Development Corporation

650 Albany Street, Suite 117, Boston, MA 02118